NEW YORK (GenomeWeb News) – DiagnoCure reported after the close of the market yesterday that it had trimmed its net loss 24 percent, while its total revenues declined 9 percent for the firm's fiscal 2009 second quarter.

The molecular diagnostics maker generated total revenues of C$467,152 (US$423,727) for the three-month period ended April 30, compared to total revenues of C$516,109 for Q2 2008. Royalty revenues from Gen-Probe tripled to C$145,107 from C$46,591 year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.